Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesEffects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet, 11/09/09
Astrup A et al. – Liraglutide treatment over 20 weeks is well tolerated, induces weight loss, improves certain obesity–related risk factors, and reduces prediabetes.
Related Articles
The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies
Diabetes, Obesity and Metabolism, 11/06/09
Relevance Score: 88%
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 87%
Diabetes Drug Helps Obese Adults Loss Weight
Diabetes News, 10/27/09
Relevance Score: 84%
A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09
Relevance Score: 83%
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet - Early Online Publication, 10/23/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Individuation of different metabolic phenotypes in normal glucose tolerance test
Acta Diabetologia, 11/25/09
Are Hemoglobin Levels Elevated in Type 1 Diabetes
Diabetes Care, 11/25/09
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor